TONBUL, H. Et Al. 2022. IN VIVO EVALUATION OF DOXORUBICIN AND ELACRIDAR CO-LOADED PLGA/SILICA HYBRID NANOPARTICLES AGAINST MULTIDRUG RESISTANT BREAST CANCER. 9th BBBB International Conference on Pharmaceutical Sciences , (Ljubljana, Slovenia), 79-80.

TONBUL, H., ŞAHİN, A., ÖZTÜRK, S. C., ULTAV, G., ESENDAĞLI, G., & ÇAPAN, Y., (2022). IN VIVO EVALUATION OF DOXORUBICIN AND ELACRIDAR CO-LOADED PLGA/SILICA HYBRID NANOPARTICLES AGAINST MULTIDRUG RESISTANT BREAST CANCER . 9th BBBB International Conference on Pharmaceutical Sciences (pp.79-80). Ljubljana, Slovenia

TONBUL, HAYRETTİN Et Al. "IN VIVO EVALUATION OF DOXORUBICIN AND ELACRIDAR CO-LOADED PLGA/SILICA HYBRID NANOPARTICLES AGAINST MULTIDRUG RESISTANT BREAST CANCER," 9th BBBB International Conference on Pharmaceutical Sciences, Ljubljana, Slovenia, 2022

TONBUL, HAYRETTİN Et Al. "IN VIVO EVALUATION OF DOXORUBICIN AND ELACRIDAR CO-LOADED PLGA/SILICA HYBRID NANOPARTICLES AGAINST MULTIDRUG RESISTANT BREAST CANCER." 9th BBBB International Conference on Pharmaceutical Sciences , Ljubljana, Slovenia, pp.79-80, 2022

TONBUL, H. Et Al. (2022) . "IN VIVO EVALUATION OF DOXORUBICIN AND ELACRIDAR CO-LOADED PLGA/SILICA HYBRID NANOPARTICLES AGAINST MULTIDRUG RESISTANT BREAST CANCER." 9th BBBB International Conference on Pharmaceutical Sciences , Ljubljana, Slovenia, pp.79-80.

@conferencepaper{conferencepaper, author={HAYRETTİN TONBUL Et Al. }, title={IN VIVO EVALUATION OF DOXORUBICIN AND ELACRIDAR CO-LOADED PLGA/SILICA HYBRID NANOPARTICLES AGAINST MULTIDRUG RESISTANT BREAST CANCER}, congress name={9th BBBB International Conference on Pharmaceutical Sciences}, city={Ljubljana}, country={Slovenia}, year={2022}, pages={79-80} }